Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination

Since the advent of direct‐acting antivirals, elimination of hepatitis C viral (HCV) infections seems within reach. However, studies on the HCV cascade of care show suboptimal progression through each step for all patient groups. Loss to follow‐up (LTFU) is a major issue and is a barrier to HCV elim...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Marleen, Drenth, Joost P.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Non‐commissioned Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693174/
https://www.ncbi.nlm.nih.gov/pubmed/32964615
http://dx.doi.org/10.1111/jvh.13399
Descripción
Sumario:Since the advent of direct‐acting antivirals, elimination of hepatitis C viral (HCV) infections seems within reach. However, studies on the HCV cascade of care show suboptimal progression through each step for all patient groups. Loss to follow‐up (LTFU) is a major issue and is a barrier to HCV elimination. This review summarizes the scale of the LTFU problem and proposes a micro‐elimination approach. Retrieving LTFU patients and re‐engaging them with care again has shown to be feasible in the Netherlands. Micro‐elimination through retrieval can contribute to reaching the World Health Organization's viral hepatitis elimination targets by 2030.

Ejemplares similares